Trixeo Aerosphere

Trixeo Aerosphere is an inhaled medication combining budesonide, glycopyrronium bromide, and formoterol fumarate dihydrate for respiratory support. This triple therapy inhaler is designed for maintenance treatment of chronic obstructive pulmonary disease (COPD). It delivers three active ingredients in a single aerosol formulation for convenient daily use.

Trixeo Aerosphere is used as a maintenance treatment for adults with moderate to severe chronic obstructive pulmonary disease (COPD). It combines an inhaled corticosteroid (budesonide) to reduce inflammation, a long-acting muscarinic antagonist (glycopyrronium bromide) to open airways, and a long-acting beta2-agonist (formoterol fumarate) for bronchodilation. This combination helps manage symptoms and reduce flare-ups in COPD patients.

Users may experience improved breathing and reduced wheezing as the medication helps keep airways open. The combination of ingredients works together to reduce inflammation in the lungs while relaxing the muscles around the airways. Regular use may help maintain consistent control of COPD symptoms over time.

Store Trixeo Aerosphere at room temperature away from moisture and heat. Keep the inhaler in its original packaging until ready to use. Rinse your mouth with water after each use to reduce the risk of oral infections. Do not expose the inhaler to extreme temperatures or direct sunlight.

Avoid using Trixeo Aerosphere with other inhaled medications unless directed by a healthcare provider. Certain medications, such as beta-blockers, may reduce the effectiveness of formoterol. Caution is advised when using with other drugs that affect heart rhythm or potassium levels. Always inform your healthcare provider about all medications you are taking.